Where does multimodal AI already perform well?
Multimodal AI—models that combine different data types like medical images, lab results, and genetic data—consistently outperforms single-modality AI. A large scoping review of 432 papers found that multimodal deep learning models improved diagnostic accuracy by an average of 6.2 percentage points in AUC (area under the curve, a key performance metric) compared to using just one data type [3]. This means that for a typical diagnostic test, the model correctly distinguishes between healthy and diseased patients more often when it has multiple sources of information.
In specific clinical tasks, multimodal systems have matched or exceeded human experts. One study found that a model combining electrocardiogram (ECG) and echocardiography outperformed human doctors in diagnosing left ventricular hypertrophy (a thickening of the heart muscle) [1]. Another study using GPT-4V, a generative AI model, achieved 80.6% diagnostic accuracy when given both medical images and text (e.g., patient history), compared to 66.7% with text alone and 45.2% with images alone [4]. These results show that integrating multiple data types can meaningfully boost performance.
Why does performance often drop in real hospitals?
The biggest hurdle is the gap between controlled research settings and messy clinical reality. A systematic review of multimodal AI in cardiovascular disease found that most models were developed and tested on fixed datasets, with very few validated in actual clinical workflows [1]. When one chest X-ray AI system was deployed in a Vietnamese hospital, its F1 score (a combined measure of precision and recall) dropped to 0.653, meaning it correctly identified abnormalities only about 65% of the time, with a sensitivity of 68.6% and specificity of 83.9% [2]. The authors noted this was a significant drop from its in-lab performance, highlighting that real-world data is noisier, less standardized, and often incomplete.
Data challenges are a major reason for this drop. Multimodal systems require integrating data from different hospital departments (radiology, pathology, genomics), which often use incompatible formats and have privacy restrictions [3][5]. A review on multimodal federated AI pointed out that data silos and privacy regulations make it difficult to train models on diverse, representative populations, limiting generalizability [5]. Until these interoperability and data-sharing issues are solved, even the best lab-tested models may stumble in practice.
What is missing for safe clinical deployment?
Several critical gaps remain. First, prospective clinical validation is rare. The cardiovascular disease review found that most multimodal models had not been tested in real-world settings, and none had undergone full deployment studies [1]. Second, trustworthiness—including fairness, explainability, and robustness—is not yet built into most systems. A 2026 review on multimodal federated AI argues that trust must be treated as a system-level property, not just accuracy, and that current models lack transparency and accountability [5].
Third, practical infrastructure is lacking. A 2022 review in Nature Medicine noted that multimodal AI requires seamless integration of electronic health records, imaging archives, and wearable data, which most hospitals cannot yet support [6]. Finally, regulatory and reimbursement pathways are unclear. The cardiovascular review explicitly calls for policy frameworks to guide scalable, trustworthy AI deployment [1]. Until these non-technical barriers are addressed, multimodal AI will remain a promising research tool rather than a reliable clinical partner.
About These Sources
This answer is built on 6 peer-reviewed studies — published from 2022 to 2026, 3 from 2024 or later, 4 in Q1 journals, collectively cited 1,003 times — selected as the most relevant from 7 studies that passed quality screening, drawn from 57 papers retrieved from a database of over 500 million.
Sources used in this answer
Mapping the landscape of multimodal and multi-omics AI/ML in cardiovascular disease: a visual framework for innovation
A systematic review of multimodal AI in cardiovascular disease found that most models remain untested in real-world clinical settings, with only a few validation-stage studies (e.g., ECG+echocardiography outperforming human experts for left ventricular hypertrophy).
Deployment and validation of an AI system for detecting abnormal chest radiographs in clinical settings
A chest X-ray AI system deployed in a Vietnamese hospital achieved an F1 score of 0.653, accuracy 79.6%, sensitivity 68.6%, and specificity 83.9%, representing a significant drop from its in-lab performance.
Navigating the landscape of multimodal AI in medicine: A scoping review on technical challenges and clinical applications
A scoping review of 432 multimodal AI papers (2018–2024) found that multimodal models outperform unimodal ones by an average of 6.2 percentage points in AUC, but face challenges including cross-departmental coordination and incomplete datasets.
Evaluating the Multimodal Capabilities of Generative AI in Complex Clinical Diagnostics
GPT-4V achieved 80.6% diagnostic accuracy with multimodal inputs (text+image) vs. 66.7% with text-only and 45.2% with image-only in 93 NEJM image challenge cases.
Multimodal Federated AI for Trustworthy and Personalized Healthcare
A review of multimodal federated AI argues that trustworthiness (privacy, fairness, explainability, robustness) must be a system-level property, and that current models lack prospective clinical validation and governance frameworks.
Multimodal biomedical AI
A 2022 Nature Medicine review outlines key applications of multimodal biomedical AI (personalized medicine, digital trials, remote monitoring) but notes major challenges in data integration, modeling, and privacy that must be overcome.